BRISTOL MYERS SQUIBB CO — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| BOERNER CHRISTOPHER S. | Chief Executive Officer | Tax Withholding | 1,238 | $46.07 | $57,035 | 1,182 | Nov 1, 2025 |
| Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | Tax Withholding | 2,665 | $46.07 | $122,777 | 19,718 | Nov 1, 2025 |
| Shanahan Karin | EVP, Chief Supply Chain & Ops | Tax Withholding | 3,213 | $46.07 | $148,023 | 16,865 | Nov 1, 2025 |
| Gallman Cari | EVP, General Counsel | Tax Withholding | 2,332 | $45.73 | $106,642 | 11,066 | Oct 2, 2025 |
| Elkins David V | EVP, Chief Financial Officer | Sale | 56,000 | $47.33 | $2,650,480 | 167,379 | Sep 2, 2025 |
| Short Bartie Wendy | EVP, Corporate Affairs | Tax Withholding | 632 | $47.18 | $29,818 | 5,669 | Sep 1, 2025 |
| Short Bartie Wendy | EVP, Corporate Affairs | Option Exercise | 738 | — | — | 5,444 | Aug 2, 2025 |
| Gallman Cari | EVP, General Counsel | Option Exercise | 1,061 | — | — | 9,383 | Aug 1, 2025 |
| BOERNER CHRISTOPHER S. | Chief Executive Officer | Gift | 62,719 | — | — | 125,439 | Jun 13, 2025 |
| Short Bartie Wendy | EVP, Corporate Affairs | Tax Withholding | 3,334 | $48.09 | $160,332 | 4,706 | Jun 3, 2025 |
| BOERNER CHRISTOPHER S. | Chief Executive Officer | Gift | 62,720 | — | — | 62,719 | Jun 3, 2025 |
| Hickey Benjamin | President, RayzeBio Org. | Sale | 97 | $38.01 | $3,702 | — | May 9, 2025 |
| Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | Purchase | 4,250 | $47.58 | $202,215 | 83,513 | Apr 25, 2025 |
| Shanahan Karin | EVP, Glob. Prod. Dev. & Supply | Tax Withholding | 1,692 | $59.55 | $100,759 | 13,797 | Apr 1, 2025 |
| Plenge Robert M | EVP, Chief Research Officer | Tax Withholding | 406 | $63.11 | $25,623 | 12,426 | Mar 10, 2025 |
| Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | Tax Withholding | 4,558 | $63.11 | $287,655 | 16,102 | Mar 10, 2025 |
| Shanahan Karin | EVP, Glob. Prod. Dev. & Supply | Other | 561 | — | — | 9,054 | Mar 10, 2025 |
| Lenkowsky Adam | EVP, Chief Commercial Officer | Tax Withholding | 771 | $63.11 | $48,658 | 8,252 | Mar 10, 2025 |
| Poole Ahn Amanda | EVP, Chief People Officer | Option Exercise | 810 | — | — | 3,643 | Mar 10, 2025 |
| LEUNG SANDRA | EVP, General Counsel | Tax Withholding | 2,298 | $63.11 | $145,027 | 354,400 | Mar 10, 2025 |
| Hoch Lynelle | President, Cell Therapy Org. | Tax Withholding | 1,359 | $63.11 | $85,766 | 4,711 | Mar 10, 2025 |
| Holzer Phil M | SVP and Controller | Option Exercise | 701 | — | — | 12,461 | Mar 10, 2025 |
| Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | Option Exercise | 5,854 | — | — | 73,929 | Mar 10, 2025 |
| Gallman Cari | EVP, Corporate Affairs | Tax Withholding | 272 | $63.11 | $17,166 | 5,705 | Mar 10, 2025 |
| Elkins David V | EVP, Chief Financial Officer | Option Exercise | 7,652 | — | — | 206,932 | Mar 10, 2025 |
| BOERNER CHRISTOPHER S. | Chief Executive Officer | Tax Withholding | 2,794 | $63.11 | $176,329 | 110,470 | Mar 10, 2025 |
| Hickey Benjamin | President, RayzeBio Org. | Option Exercise | 3,286 | — | — | 10,419 | Mar 1, 2025 |
| BOERNER CHRISTOPHER S. | Chief Executive Officer | Purchase | 2,000 | $55.05 | $110,100 | 104,626 | Feb 20, 2025 |
| Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | Purchase | 1,823 | $54.84 | $100,000 | 63,932 | Feb 14, 2025 |
| Hickey Benjamin | President, RayzeBio Org. | Tax Withholding | 3,725 | $58.95 | $219,589 | 7,133 | Feb 1, 2025 |
| Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | Option Exercise | 2,543 | — | — | 7,829 | Feb 1, 2025 |
| Holzer Phil M | SVP and Controller | Sale | 700 | $55.62 | $38,934 | 11,760 | Nov 4, 2024 |
| BOERNER CHRISTOPHER S. | Chief Executive Officer | Other | 55 | — | — | 104,114 | Nov 1, 2024 |
| Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | Purchase | 1,830 | $54.68 | $100,064 | 62,109 | Nov 1, 2024 |
| Gallman Cari | EVP, Corporate Affairs | Tax Withholding | 1,648 | $53.76 | $88,596 | 5,019 | Oct 2, 2024 |
| Gallman Cari | EVP, Corporate Affairs | Tax Withholding | 384 | $48.17 | $18,497 | 2,109 | Aug 1, 2024 |
| Shanahan Karin | EVP, Glob. Prod. Dev. & Supply | Option Exercise | 3,306 | — | — | 6,532 | Apr 1, 2024 |
| Lenkowsky Adam | EVP, Chief Commercial Officer | Option Exercise | 1,698 | — | — | 2,224 | Mar 10, 2024 |
| LEUNG SANDRA | EVP, General Counsel | Option Exercise | 5,856 | — | — | 339,657 | Mar 10, 2024 |
| Plenge Robert M | EVP, Chief Research Officer | Option Exercise | 6,985 | — | — | 15,182 | Mar 10, 2024 |
| Poole Ahn Amanda | EVP, Chief Human Resources | Tax Withholding | 207 | $53.79 | $11,135 | 701 | Mar 10, 2024 |
| Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | Other | 660 | — | — | 50,777 | Mar 10, 2024 |
| Holzer Phil M | SVP and Controller | Other | 121 | — | — | 10,920 | Mar 10, 2024 |
| Hoch Lynelle | President, Cell Therapy Org. | Tax Withholding | 197 | $53.79 | $10,597 | 257 | Mar 10, 2024 |
| Gallman Cari | EVP, Corporate Affairs | Other | 60 | — | — | 666 | Mar 10, 2024 |
| BOERNER CHRISTOPHER S. | Chief Executive Officer | Tax Withholding | 2,957 | $53.79 | $159,057 | 87,859 | Mar 10, 2024 |
| Elkins David V | EVP, Chief Financial Officer | Option Exercise | 8,042 | — | — | 181,064 | Mar 10, 2024 |
| Caforio Giovanni | Executive Chair of the Board | Tax Withholding | 10,084 | $53.79 | $542,418 | 386,758 | Mar 10, 2024 |
| Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | Tax Withholding | 754 | $48.67 | $36,697 | 5,286 | Feb 1, 2024 |
| BOERNER CHRISTOPHER S. | Chief Executive Officer | Purchase | 2,000 | $49.78 | $99,560 | 82,672 | Dec 5, 2023 |